Electroconductive carbon fibril-based inks and coatings

Details for Australian Patent Application No. 2003238250 (hide)

Owner Hyperion Catalysis International, Inc.

Inventors Nui, Chunming; Ma, Jun; Fischer, Alan B.; Ngaw, Lein

Agent Spruson & Ferguson

Pub. Number AU-B-2003238250

PCT Number PCT/US03/19068

PCT Pub. Number WO2003/107359

Priority 60/388,616 14.06.02 US

Filing date 16 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 11 June 2009

International Classifications

H01B 1/00 (2006.01) Conductors or conductive bodies characterised by the conductive materials

C09D 5/24 (2006.01) Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced - Electrically-conducting paints

C09D 11/00 (2006.01) Inks

H01B 1/24 (2006.01) Conductors or conductive bodies characterised by the conductive materials - the conductive material comprising carbon-silicon compounds, carbon, or silicon

H01C 17/065 (2006.01) Apparatus or processes specially adapted for manufacturing resistors

H01G 9/058 (2006.01) Electrolytic capacitors, rectifiers, detectors, switching devices, light-sensitive or temperature-sensitive devices - specially adapted for double-layer capacitors

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/388,616 14.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003238250

11 June 2009 Application Accepted

  Published as AU-B-2003238250

8 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003238251-Inhibition of T cell activation by butyrophilin 4 or B7-L1

2003238249-USE OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR)-Gamma LIGANDS AS A TREATMENT FOR PITUITARY TUMORS AND ASSOCIATED CONDITIONS, SUCH AS CUSHING'S SYNDROME